The Standing Committee of the 13th National People's Congress issued the draft Amendment to the Company Law ("Amended Company Law") on December 24, 2021 for comment through January 22, 2022.

After a long wait since foreign investment in partnerships formed under PRC law was first permitted on 1 March 2010, the authorities in Shanghai jointly published Implementing Measures for a Pilot Program in respect of Foreign Invested Private Equity Investment Enterprises (the "Measures") on 11 January 2011.

By the time we went to publish this interview, it was a significant factor in the state of venture capital investing and, more broadly, our global economy.

The new Company Law of the People’s Republic of China ("New Law"), which was adopted by the Standing Committee of the National People’s Congress on October 27, 2005, came into force on January 1, 2006.

The Provisional Measures for the Administration of Venture Capital Enterprises (the "Provisional Measures") were jointly promulgated by 10 Mainland Chinese agencies on 15 November 2005 and will take effect from 1 March 2006.

继中国证券监督管理委员会于2026年2月27日发布《私募投资基金信息披露监督管理办法》（以下简称《监督办法》）后，2026年3月13日，中国证券投资基金&#

On August 8, 2006, six PRC ministries jointly promulgated a set of far-reaching rules that have changed the landscape for foreign mergers and acquisitions, offshore listings of Chinese companies, and the restructurings of PRC companies, which commonly precede foreign investment of venture capital and private equity. The Rules became effective as of September 8, 2006.

On January 19, 2015, China’s Ministry of Commerce released for public comment a draft Foreign Investment Law along with an accompanying explanatory note.

This is the first case in China where a court denied the validity of an agreement with a valuation adjustment mechanism.

A Paris roundtable examined China's transformation into a biotechnology powerhouse and the strategic opportunities this creates for European life sciences companies and investors. Industry leaders discussed how to structure cross-border partnerships that leverage Chinese innovation and development speed while navigating intellectual property protection, regulatory frameworks, and evolving geopolitical considerations.

The Chinese pharmaceutical market is experiencing double-digit growth and will become the world’s second-largest market after the United States by 2016, according to IMS Health.

A secret pre-IPO agreement containing a valuation adjustment mechanism (VAM) has been declared invalid by the Shanghai High People's Court lately, arousing concerns...

Recent regulatory changes for the first time allow foreign investors to directly acquire shares in a company listed in a Mainland China stock exchange. This expands further the investment opportunities for foreign strategic and financial investors.

The State Administration of Foreign Exchange (the "SAFE") promulgated Circular on Issues Relating to Foreign Exchange Administration of Equity Financings and Return Investments by Domestic Residents through Offshore Special Purpose Vehicles ("Circular 75" or the "Circular") on October 21, 2005, which legalizes, and further regulates, the offshore holding company structure favored by private enterprises in their offshore fundraising activities with a view toward channeling foreign ventu

2019年3月8日，中国恒大研究院发布《中国独角兽报告2019》，筛选出161家估值10亿美元以上的独角兽企业，蚂蚁金服、今日头条、滴滴出行以1,500亿美元、

从融资方的角度看，总是希望高估其价值，以便以尽可能少的股权换取尽可能多的投资；从投资方角度看，总是希望低买高卖，即以较少投资!

保险资金运用近年来发展迅速，截至2019年11月底，累计发起设立各类债权、股权投资计划1,265项，合计备案（注册）规模29,119.18亿元。[1]监管政策对保险ũ

本文拟结合中国并购贷款市场的现状与数据表现，系统梳理《并购贷款新规（稿）》的主要修订内容，并探讨其对商业银行并购贷款业务开展的潜

2020年春节前夕，"新冠肺炎"...

2019年1月30日公布的《上海证券交易所科创板股票上市规则》（下称"《上市规则（征求意见稿）》"），针对科创板市场的定位及该板上市公司的特